Mobia Medical (NASDAQ:MOBI) Posts Earnings Results

Mobia Medical (NASDAQ:MOBI) announced its earnings results on Thursday. The company reported ($0.52) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.46) by ($0.06), FiscalAI reports. The firm had revenue of $15.62 million during the quarter. Mobia Medical’s quarterly revenue was up 73.3% compared to the same quarter last year.

Here are the key takeaways from Mobia Medical’s conference call:

• Third-quarter revenue rose 73% year over year to $15.6 million, ahead of expectations, prompting Mobia to raise its 2026 revenue outlook to $57.0 million–$57.5 million from $54 million–$56 million.
• Growth was driven disproportionately by adoption at existing programs, while average active territories increased 78% year over year to 40. Management said it plans to keep adding territories at a measured, consistent pace.
• Mobia pointed to the inclusion of paired vagus nerve stimulation in updated AHA/ASA stroke recovery guidelines and favorable reimbursement infrastructure, including a Category 1 CPT code and an average Medicare payment of about $45,000, as factors supporting adoption. Management said the recent OPPS rule supports its reimbursement strategy.
• Operating expenses increased to $31.5 million from $18.4 million, largely reflecting commercial hiring and higher stock-based compensation, and the quarterly net loss widened to $17.3 million from $11.4 million. The company reported $160.7 million in cash and said it expects gross margin to remain in the low 80% range.

Mobia Medical Trading Up 0.4%

Shares of NASDAQ MOBI traded up $0.04 during trading on Thursday, reaching $11.28. The company had a trading volume of 183,306 shares, compared to its average volume of 166,298. Mobia Medical has a 12-month low of $8.03 and a 12-month high of $15.29. The company has a current ratio of 13.28, a quick ratio of 12.80 and a debt-to-equity ratio of 0.04. The business’s 50-day moving average is $9.99.

Insiders Place Their Bets

In other news, Director Casey Tansey bought 16,441 shares of the firm’s stock in a transaction on Tuesday, August 18th. The stock was acquired at an average cost of $12.07 per share, with a total value of $198,442.87. Following the completion of the acquisition, the director owned 318,332 shares of the company’s stock, valued at approximately $3,842,267.24. This represents a 5.45% increase in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. In the last three months, insiders have bought 87,000 shares of company stock worth $1,016,367.

Institutional Trading of Mobia Medical

A number of institutional investors and hedge funds have recently modified their holdings of MOBI. Readystate Asset Management LP bought a new stake in Mobia Medical in the 2nd quarter worth about $134,000. Citadel Advisors LLC bought a new position in shares of Mobia Medical during the 2nd quarter valued at $670,000. State Street Corp purchased a new position in shares of Mobia Medical in the 2nd quarter worth $735,000. Finally, University of Texas Texas AM Investment Management Co. purchased a new position in shares of Mobia Medical in the 3rd quarter worth $1,019,000.

Analysts Set New Price Targets

Several research firms recently weighed in on MOBI. BTIG Research restated a “buy” rating and set a $19.00 price target on shares of Mobia Medical in a research report on Tuesday, October 20th. JPMorgan Chase & Co. upped their price target on Mobia Medical from $15.00 to $17.00 and gave the stock an “overweight” rating in a research note on Wednesday, August 12th. Finally, Weiss Ratings started coverage on Mobia Medical in a report on Wednesday, August 12th. They issued a “sell (e-)” rating for the company. Five equities research analysts have rated the stock with a Buy rating, one has given a Hold rating and one has given a Sell rating to the stock. According to MarketBeat, the stock presently has an average rating of “Moderate Buy” and an average price target of $20.75.

Mobia Medical Company Profile

Mobia Medical Inc is a commercial-stage medical device company redefining stroke recovery for survivors living with life-altering motor impairments. Mobia Medical Inc is based in AUSTIN, Texas.